New sleep drug shows promise for narcolepsy patients

NCT ID NCT06792708

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study followed 71 adults with narcolepsy who started taking LUMRYZ, a medication for excessive daytime sleepiness. Over 4 months, participants filled out questionnaires about their symptoms, how they felt about the drug, and their quality of life. The goal was to see if LUMRYZ helps reduce sleepiness in real-world settings, not to find a cure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NARCOLEPSY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Abington Neurological Associates

    Abington, Pennsylvania, 19001, United States

  • Bogan Sleep Consultants

    Columbia, South Carolina, 29201, United States

  • Comprehensive Sleep Center

    East Lansing, Michigan, 48823, United States

  • Ghaly Sleep Management Services

    East Syracuse, New York, 13057, United States

  • Jeremy D McConnell, MD PA

    Bradenton, Florida, 34209, United States

  • Northwest Houston Neurology

    Tomball, Texas, 77375, United States

  • Ohio Sleep Medicine Institute

    Dublin, Ohio, 43017, United States

  • Patient First MD

    Middletown, New Jersey, 07748, United States

  • Pulmonology Associates, Inc.

    Wynnewood, Pennsylvania, 19096, United States

  • Respiratory Specialists

    Wyomissing, Pennsylvania, 19610, United States

  • Tricoastal Narcolepsy and Sleep Disorder Center

    Sugar Land, Texas, 77478, United States

  • University Hospitals Cleveland Medical Center

    Cleveland, Ohio, 44106, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.